Paul Tudor Jones Abbott Laboratories Transaction History

Tudor Investment Corp Et Al

$19.2 Billion
Q2 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Abbott Laboratories stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 197,329 shares of ABT stock, worth $22.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

197,329

Previous 493,050 59.98%

Holding current value

$22.2 Million

Previous $56 Million 63.41%

% of portfolio

0.11%

Previous 0.36%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $29.8 Million - $33.3 Million	-295,721 Reduced 59.98%	197,329 $20.5 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $46.9 Million - $51.8 Million	428,413 Added 662.8%	493,050 $56 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $7.99 Million - $9.78 Million	-88,590 Reduced 57.82%	64,637 $7.11 Million
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $14.6 Million - $17.6 Million	153,227 New	153,227 $14.8 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $13.5 Million - $15.9 Million	139,628 New	139,628 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $3.2 Million - $3.7 Million	33,021 New	33,021 $3.2 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $2.95 Million - $3.6 Million	25,872 Added 38.01%	93,944 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $4.28 Million - $4.74 Million	36,722 Added 117.14%	68,072 $8.04 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.82 Million - $2.14 Million	17,196 Added 121.49%	31,350 $3.63 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $5.72 Million - $6.74 Million	-52,577 Reduced 78.79%	14,154 $1.7 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $7.01 Million - $7.64 Million	66,731 New	66,731 $7.31 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $2.78 Million - $3.37 Million	-30,325 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $2.32 Million - $2.97 Million	30,325 New	30,325 $2.77 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $3.73 Million - $5.45 Million	-59,324 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $4.66 Million - $5.18 Million	59,324 New	59,324 $5.15 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $328,374 - $396,144	-5,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $310,878 - $343,116	5,400 New	5,400 $329,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account